This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Groll AH et al. (2001) Prevention of fungal infections in children and adolescents with cancer [German]. Klin Padiatr 213 (Suppl 1): SA50–SA68
Marr KA et al. (2004) Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 103: 1527–1533
Slavin MA et al. (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double-blind study. J Infect Dis 171: 1545–1552
De Pauw BE and Donnelly JP (2007) Prophylaxis and aspergillosis—has the principle been proven? N Engl J Med 356: 409–411
Ullmann AJ et al. (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356: 335–347
Acknowledgements
The synopsis was written by Helen Jaques, Editorial Assistant, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author has declared associations with the following companies: research support from Gilead Sciences, Merck Sharpe & Dohme and Pfizer; and consultation and speaker fees from Astellas Pharma, Gilead Sciences, Merck Sharpe & Dohme, Pfizer, Schering-Plough and Unichem
Rights and permissions
About this article
Cite this article
Groll, A. Does posaconazole prevent invasive fungal infections in patients with neutropenia?. Nat Rev Clin Oncol 4, 512–513 (2007). https://doi.org/10.1038/ncponc0907
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0907